Target Name: KRBOX1
NCBI ID: G100506243
Other Name(s): KRAB box domain containing 1 | KRBX1_HUMAN | KRAB domain-containing protein 1

KRBOX1: A Potential Drug Target and Biomarker

KRBOX1, also known as KRBOX1L, is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and function have made it an attractive target for researchers to investigate, and recent studies have shed light on its potential as a drug.

The KRBOX1 gene is located on chromosome 6 and encodes a protein known as KRBOX1. This protein plays a crucial role in the regulation of cellular processes, including cell adhesion, migration, and invasion. KRBOX1 has also been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key features of KRBOX1 is its potential to interact with several different drug targets. This has led to its potential as a drug target, as drugs that target KRBOX1 may have a greater impact on disease progression and treatment outcomes. For example, studies have shown that inhibiting KRBOX1 has the potential to slow the growth of cancer cells and improve the efficacy of certain neurodegenerative drugs.

In addition to its potential as a drug target, KRBOX1 has also been identified as a potential biomarker. Its expression has been shown to be affected by a variety of factors, including disease stage, treatment, and environmental factors. This makes it a promising biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the challenges in studying KRBOX1 as a drug target and biomarker is its complex structure and function. While researchers have made significant progress in understanding its role in disease, much more work is needed to fully understand its potential as a drug.

In conclusion, KRBOX1 is a gene that has the potential to be a drug target and biomarker for a variety of diseases. Its unique structure and function make it an attractive target for researchers to investigate, and recent studies have shown that it has the potential to have a significant impact on disease progression and treatment outcomes. Further research is needed to fully understand its potential as a drug and to develop effective treatments.

Protein Name: KRAB Box Domain Containing 1

More Common Targets

KRBOX1-AS1 | KRBOX4 | KRBOX5 | KRCC1 | KREMEN1 | KREMEN2 | KRI1 | KRIT1 | KRR1 | KRT1 | KRT10 | KRT10-AS1 | KRT12 | KRT126P | KRT13 | KRT14 | KRT15 | KRT16 | KRT16P1 | KRT16P2 | KRT16P3 | KRT16P6 | KRT17 | KRT17P1 | KRT17P2 | KRT17P3 | KRT17P5 | KRT17P7 | KRT18 | KRT18P1 | KRT18P12 | KRT18P13 | KRT18P16 | KRT18P17 | KRT18P19 | KRT18P22 | KRT18P23 | KRT18P24 | KRT18P27 | KRT18P28 | KRT18P29 | KRT18P31 | KRT18P33 | KRT18P34 | KRT18P4 | KRT18P40 | KRT18P41 | KRT18P42 | KRT18P44 | KRT18P48 | KRT18P49 | KRT18P5 | KRT18P50 | KRT18P51 | KRT18P55 | KRT18P59 | KRT18P6 | KRT18P62 | KRT19 | KRT19P2 | KRT19P3 | KRT2 | KRT20 | KRT222 | KRT23 | KRT24 | KRT25 | KRT26 | KRT27 | KRT28 | KRT3 | KRT31 | KRT32 | KRT33A | KRT33B | KRT34 | KRT35 | KRT36 | KRT37 | KRT38 | KRT39 | KRT4 | KRT40 | KRT42P | KRT5 | KRT6A | KRT6B | KRT6C | KRT7 | KRT7-AS | KRT71 | KRT72 | KRT73 | KRT73-AS1 | KRT74 | KRT75 | KRT76 | KRT77 | KRT78 | KRT79